» Articles » PMID: 20093813

Haemodialysis-induced Myocardial Stunning in Chronic Kidney Disease - a New Aspect of Cardiovascular Disease

Overview
Journal Blood Purif
Specialty Hematology
Date 2010 Jan 23
PMID 20093813
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic haemodialysis (HD) patients are already primed by a large number of structural and functional peripheral vascular and cardiac abnormalities to experience demand myocardial ischaemia. Transient myocardial ischaemia may lead to left ventricular (LV) dysfunction that can persist after the return of normal perfusion. This prolonged dysfunction is known as myocardial stunning. Repetitive episodes of ischaemia can be cumulative and have been shown to lead to prolonged LV dysfunction (in patients with ischaemic heart disease). Conventional HD itself is a sufficient cardiovascular functional stressor to precipitate such recurrent ischaemic insults, leading to myocardial functional and structural changes, eventually resulting in fixed systolic dysfunction and heart failure (conferring a dismal prognosis for patients undergoing dialysis). Furthermore these same haemodynamic insults may also adversely affect other vascular beds in other vulnerable organ systems, driving an even wider range of pathophysiological processes. A variety of therapeutic manoeuvres aimed at improving the haemodynamic tolerability of treatment have been shown to reduce acute dialysis-induced myocardial ischaemia. This article aims to give an appreciation of the possibility that modification of the dialysis treatment to improve tolerability of therapy may have the potential to provide us with additional therapeutic targets, to reduce currently excessive rates of cardiovascular morbidity and mortality.

Citing Articles

The complex role of cardiovascular imaging in viability testing.

Nealy Z, Wang S, Patel A Prog Cardiovasc Dis. 2025; 88:113-125.

PMID: 39788340 PMC: 11835452. DOI: 10.1016/j.pcad.2024.12.008.


The Janus-faced nature of complement in hemodialysis: interplay between complement, inflammation, and bioincompatibility unveiling a self-amplifying loop contributing to organ damage.

Canaud B, Stenvinkel P, Scheiwe R, Steppan S, Bowry S, Castellano G Front Nephrol. 2024; 4:1455321.

PMID: 39691704 PMC: 11649546. DOI: 10.3389/fneph.2024.1455321.


Analysis of prefrontal cerebral blood volume and flow changes in ESKD patients undergoing hemodialysis using functional near-infrared spectroscopy.

Heo C, Yi J, Park K, Lee D, Lee Y, Park B Ren Fail. 2024; 46(2):2387426.

PMID: 39135525 PMC: 11328595. DOI: 10.1080/0886022X.2024.2387426.


What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?.

Cristol J, Thierry A, Bargnoux A, Morena-Carrere M, Canaud B Front Med (Lausanne). 2023; 10:1268748.

PMID: 38034546 PMC: 10684960. DOI: 10.3389/fmed.2023.1268748.


Feedback control in hemodialysis.

Randhay A, Eldehni M, Selby N Semin Dial. 2023; 38(1):62-70.

PMID: 37994191 PMC: 11867153. DOI: 10.1111/sdi.13185.